[HTML][HTML] Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
K Hemminki, A Försti, A Hemminki, B Ljungberg… - PLoS …, 2021 - journals.plos.org
… survival experience in Finland and Sweden over a period of … 1987–1991 and then declined
to the starting level; after 2002 … patients had distant metastases and the mean tumor size was …
to the starting level; after 2002 … patients had distant metastases and the mean tumor size was …
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …
B Ljungberg, P Sundqvist, P Lindblad… - … journal of urology, 2020 - Taylor & Francis
… to the Swedish National Population Register for overall survival … The present study in the
early TKI era, suggests that in a … -risk patients, since all had synchronous metastatic disease […
early TKI era, suggests that in a … -risk patients, since all had synchronous metastatic disease […
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study
S Demasure, I Spriet, PR Debruyne, A Laenen… - Acta …, 2022 - Taylor & Francis
… (the cytokin era, which was in our study predominantly IFNa), … study including 4.217 Swedish
patients diagnosed with mRCC between 2002 and 2005, 2006 and 2008 or 2009 and 2012…
patients diagnosed with mRCC between 2002 and 2005, 2006 and 2008 or 2009 and 2012…
Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis
J Redig, J Dalén, U Harmenberg… - … and Research, 2019 - Taylor & Francis
… Overall survival and factors influencing overall survival in this … treated in the period 2002
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic …
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic …
[HTML][HTML] Treatment of advanced renal cell carcinoma: immunotherapies have demonstrated overall survival benefits while targeted therapies have not
O Hemminki, N Perlis, J Bjorklund, A Finelli… - European urology open …, 2020 - Elsevier
… listed as a treatment option for metastatic renal cell carcinoma in … During this time period,
indications for surgery have remained … However, an ad hoc subgroup analysis suggested no OS …
indications for surgery have remained … However, an ad hoc subgroup analysis suggested no OS …
Metastatic papillary renal cell carcinoma in the era of targeted therapy–a retrospective study from three European academic centres
M Stenman, M Staehler, B Szabados… - Acta …, 2019 - Taylor & Francis
… (n = 86) referred to three academic centres in Sweden and … The aim of the study was to
evaluate overall survival (OS) of … Moreover, for patients with synchronous metastases …
evaluate overall survival (OS) of … Moreover, for patients with synchronous metastases …
Comparative survival associated with use of targeted vs nontargeted therapy in medicare patients with metastatic renal cell carcinoma
P Li, J Jahnke, AR Pettit, YN Wong… - JAMA Network …, 2019 - jamanetwork.com
… , 36 our subgroup analysis of patients who had undergone … 44 ; in our study, unadjusted
median overall survival for the … our study period, and a recent analysis found greater survival …
median overall survival for the … our study period, and a recent analysis found greater survival …
[HTML][HTML] Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study
T Almdalal, P Sundqvist, U Harmenberg… - European Urology Open …, 2022 - Elsevier
… the Swedish Cancer Register where all patients with any cancer … metastases in patients
treated with ablation versus those … Urology guidelines on renal cell carcinoma: the 2019 update …
treated with ablation versus those … Urology guidelines on renal cell carcinoma: the 2019 update …
Inflammatory response markers and survival prediction in patients with renal cell carcinoma
A Mountzias, J Hultdin, J Hlodan… - … journal of urology, 2022 - Taylor & Francis
… being alive in the Swedish National Population Register. The last … The updated TNM
classification 2017 was used for tumour … The mean overall survival for alive patients were 9.5 …
classification 2017 was used for tumour … The mean overall survival for alive patients were 9.5 …
Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus
Y Ishiyama, T Kondo, H Tachibana, H Ishihara… - … Oncology: Seminars and …, 2022 - Elsevier
… Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous …
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous …